Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-9 of  9 results for ""Heart Failure""

Your Filters

Publisher : american medical association Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Geographic : north america Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes.

  • Authors : Essien UR; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles.; Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, California.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: JAMA network open [JAMA Netw Open] 2023 Jun 01; Vol. 6 (6), pp. e2316290. Date of Electronic Publication: 2023 Jun 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

FDA Expands Empagliflozin Heart Failure Indication.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: JAMA [JAMA] 2022 Apr 05; Vol. 327 (13), pp. 1219.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.

  • Authors : Htoo PT; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Tesfaye H

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: JAMA network open [JAMA Netw Open] 2022 Oct 03; Vol. 5 (10), pp. e2237606. Date of Electronic Publication: 2022 Oct 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.

  • Authors : Zhou T; Yale School of Medicine, New Haven, Connecticut.; Liu P

Subjects: Atrial Fibrillation* ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*

  • Source: JAMA internal medicine [JAMA Intern Med] 2022 Feb 01; Vol. 182 (2), pp. 185-195.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534

Record details

Read More Add to Saved list
×
Academic Journal

Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.

Subjects: Stroke Volume*; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/Glucagon-Like Peptide 1/*agonists

  • Source: JAMA [JAMA] 2016 Aug 02; Vol. 316 (5), pp. 500-8.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin/Insulin/Insulin/*therapeutic use

  • Source: JAMA [JAMA] 2020 Jun 16; Vol. 323 (23), pp. 2419-2420.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
Academic Journal

Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.

  • Authors : Edmonston D; Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.; Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2418808. Date of Electronic Publication: 2024 Jun 03.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Association of Cardiovascular Outcomes and Mortality With Sustained Long-Acting Insulin Only vs Long-Acting Plus Short-Acting Insulin Treatment.

  • Authors : Schroeder EB; Kaiser Permanente Colorado Institute for Health Research, Aurora.; Parkview Health, Fort Wayne, Indiana.

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*epidemiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: JAMA network open [JAMA Netw Open] 2021 Sep 01; Vol. 4 (9), pp. e2126605. Date of Electronic Publication: 2021 Sep 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235

Record details

Read More Add to Saved list
×
Academic Journal

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

  • Authors : Nissen SE; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ; Wolski K

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*mortality ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glycine/Glycine/Glycine/*analogs & derivatives

  • Source: JAMA [JAMA] 2005 Nov 23; Vol. 294 (20), pp. 2581-6. Date of Electronic Publication: 2005 Oct 20.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

Read More Add to Saved list
×
  • 1-9 of  9 results for ""Heart Failure""